Professor Ian Ford
After completing his PhD in 1976, Professor Ford spent a year as a lecturer at the University of Wisconsin-Madison. He returned to the University of Glasgow in 1977 where he has held appointments as lecturer, senior lecturer, reader and Professor of Statistics. He is currently Professor of Biostatistics at the University and Director of the Robertson Centre for Biostatistics. He is a former Head of the University's Department of Statistics and former Dean of the Faculty of Information and Mathematical Sciences. He is Director of the NIHR CRN registered Glasgow Clinical Trials Unit and is Assistant Director (with responsibility for Biostatistics and Informatics) for the United Kingdom Stroke Research Network (SRN) and currently chairs the Operational Steering Group of the SRN.
Professor Ford has research interests in the design, conduct, analysis and interpretation of clinical trials and epidemiological studies, in biostatistical methods and in the use of novel electronic tools to enhance the conduct of clinical research, particularly related to the use of routinely collected health data. He has published widely in the statistical, epidemiological and clinical medicine literature. He has contributed significantly to the design, conduct and interpretation of many completed large landmark clinical trials, especially in cardiovascular disease, including WOSCOPS, PROSPER, CAPRICORN, TIBET, IONA, BEAUTifUL and sits on the Executive committees of a number of major ongoing trials (ECHO-CRT, DOT-HF, SCOT, SHIFT, FAST PERFORM). He chairs and is a member of numerous Independent Data Monitoring Committees and is a member of the Scientific Steering Committee of the Generation Scotland: Scottish Family Health Study. He has served on a number of editorial boards (currently PLoS Medicine, Statistical Methods for Medical Research and the Journal of Evaluation in Clinical Practice), is a Fellow of the Royal Society of Edinburgh, the International Statistical Institute and is Fellow qua physician ad eundem of the Royal College of Physicians of Glasgow.
Selected journal articles
- Ford, I; Bezlyak, V; Stott, DJ; Sattar, N; Packard, CJ; Perry, I; Buckley, BM; Jukema, JW; De Craen, AJM; Westendorp, RGJ; Shepherd, J. (2009) Reduced Glomerular Filtration Rate and Its Association with Clinical Outcome in Older Patients at Risk of Vascular Events: Secondary. PLOS MEDICINE, 6 (1): 76-82.
- Fox, K, Ford, I, Steg, PG, Tendera, M, Robertson, M, Ferrari, R. (2008) Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial. Lancet, 372; 817-821.
- Fox, K, Ford, I, Steg, PG, Tendera, M, Ferrari, R. (2008) Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial. Lancet, 372; 807-816.
- Naveed Sattar, Alex McConnachie, A Gerald Shaper, Gerard J Blauw, Brendan M Buckley, Anton J de Craen, Ian Ford, Nita G Forouhi, Dilys J Freeman, J Wouter Jukema, Lucy Lennon, Peter W Macfarlance, Michael B Murphy, Chris J Packard, David J Stott, Rudi G Westendorp, Peter H Whincup, James Shepherd, S Goya Wannamethee (2008). "Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies." Lancet, 371 (9628): 1927-35
- Brouilette SW, Moore JS, McMahon A, Thompson JR, Ford I, Shepherd J, Packard CJ, Samani NJ (2007). "Telomere length, risk of coronary heart disease, and statin treatment in the West of Scotland Primary Prevention Study: a nested case-control study". Lancet, 369 (9556): 107-114.
- McCarey,D.W.,McInnes,I.B.,Madhok,R.,Hampson,R.,Sherbakova,O.,Ford,I., Capell,H.A., Sattar,N. (2004). "Trial of Atorvastatin in Rheumatoid Arthritis(TARA): double blind , randomised placebo controlled trial." Lancet, 363(9426): 2015-2021.
- Ford I, Murray H, Packard C et al (2007). "Long-term Follow-up of the West of Scotland Coronary Prevention Study". New England Journal of Medicine: 357; 1477-86